MMP12 and achalasia-alacrima syndrome: In conclusion, our current findings confirm a deleterious role for aberrant MMP-12 activity in atherosclerotic aneurysm formation and rupture as demonstrated by the protective effect afforded on the formation and progression of established AAAs through MMP-12 inhibition with RXP470.1.